The best gym, fitness and bodybuilding shirts online!

There’s a huge supply of gym, bodybuilding and fitness shirts online, so where do you start?

Miscshirts.com is a premium gym and fitness clothing store that ships internationally to almost all modern countries, including Asia, the UK, US and Australia to name a few. They have a huge range of products, from hoodies to shirts, gym bags to iphone cases, and tank tops to sweatshirts. Something for everyone!

The designs at Miscshirts are all custom designed, so you can rest assured what you’re seeing on this site won’t be at your local Target or anything like that. Designs are regularly updated and rotated, with multiple new designs going up every month! But relax, all your old favourite designs get archived, so you tear your favourite -light weight baby- shirt in the gym, you can get another!

Obviously, there are the -misc- targeted products, directed at the bodybuilding.com misc forum, the designs range from funny misc memes to more serious, everyday gym wear.

Miscshirts operates through Cafepress, a globally trusted and proven clothing producer and distributor. Their products are all guaranteed to be of the highest quality, and in fact, their fitted t-shirts are American Apparel, a brand known for the quality of their shirts!

They also have special offers and deals they post on their facebook and through their mail list, so be sure to get onto that. But in all honesty the prices are very reasonable for the designs and products they offer.

Buying shirts and other gym wear online is super easy and streamlined. You just ad your products to cart, put in your details, and checkout! Then wait for the product to arrive on your doorstep. Shipping generally takes a week if you’re in the US, and a couple more weeks if you live elsewhere.

Cafepress offers a 30-day money back guarantee on all their products (every product from miscshirts.com), so there’s really nothing to lose. If you don’t li,e the product, send it back, get your money back, easy.

In summary, Miscshirts.com offers a big range of designs

Prostate Cancer Research

Prostate cancer research is ongoing to help find a cure and it won’t stop until there is a cure for it. Researchers believe that genes are linked to the cancer and this helps find more answers about any genetic changes. Once the researcher’s link into this and find that this is the cause; medicines will be made to target the genes to see what can be done to prevent this type of cancer. While one can inherit his genes from his parents, there is a gene that he inherits from his mother that can triple his risk of getting prostate cancer.

As the prostate cancer research continues they are looking into which cancers stay in the gland and which ones grow and spread. Researcher’s know that one gene is only appearing more in the advanced stages then in the earlier stages of cancer and if this continues they are looking to see if that would mean that when that gene is present the cancer is aggressive. The result of this research would let us know which men need treatment and which men just need to be watched that the cancer does not progress. When we hear things like this we do know that the prostate cancer research team is almost there to help us perhaps one day rid us of this cancer.

When doctors want to measure the blood flow in the gland they use a Doppler ultrasound. This ultrasound will help to find the right part of the gland that should be tested so the test would be as correct as it can be. Having an exact prostate cancer diagnosis will help in curing the person faster. Something more advanced is injecting the person with a contrast and better results were found for a prostate cancer diagnosis as this was used but it’s not for the public because it’s still being tested. MRI’s might also be useful for a prostate cancer diagnosis but that is still in being studied at the moment.

There were some substances that were found in tomatoes and in soybeans that may help

Keep An Eye On Alzheimer’s Disease

The term dementia refers to a brain disorder that demonstrates itself in several ways. A person may easily become confused even in known settings, may ask questions repeatedly, or may neglect such basic things as their own hygiene or basic safety issues. Alzheimer’s disease is the most common form of dementia linked with old age.

The disease is named after German Doctor Alois Alzheimer. In 1906, Doctor Alzheimer discovered differences in the brain tissue of a patient of his that died with unusual mental illnesses and dementia. His study directed him to find out anomalous clumps and tangles of fiber in the brains of those patients who were suffering from this same disease.

Thus, whilst it was common for persons who were older and losing their mental faculties to be dismissed as “senile,” Dr. Alzheimer was able to pinpoint the actual breakdown in the brain that led to the loss of their mental faculties.

According to the National Institute on Aging varied test conclusions, there are actual brain changes in persons with Alzheimer’s disease. They can find out how nerve cells die in areas of the brain that affect memory and basic abilities. It may seem strange, but everything that we do on a daily basis is because of memory.

We remember that we need to take a shower on a regular basis that we need to shut the door behind us when we exit the house. We don’t realize that we’re doing these things because of memory, and assume that they just happen naturally. But when those memories break down because of Alzheimer’s or any other mental disorder, even the most basic daily functions begin to be confusing or neglected.

Actually, the brain works by a series of connections between nerve endings, all of which are related. For example, the part of the brain that controls speech sends signals to the nerves that trigger the muscles and parts of the mouth when we want to talk. Certainly, all of our mental and physical functions work this way.

With Alzheimer’s disease, these nerve signals are disrupted or broken. If the

Accessible Elderly Home Health Care in New York

Locating accessible home health care in New York can be difficult if you do not know where to look. There are many different triggers for admission to Home Health Care, and every single person is handled on a case by case basis.

Certain people require the care post surgery during recovery, some may be undergoing certain infusion treatments, and others may be suffering from a chronic illness. Whatever the issue is, if you or your loved one would prefer to stay at home as opposed to a relocate to a facility, review your options thoroughly and carefully.

Having access to home care is very important to New Yorkers. We want quality health care and if it can come to us instead of going to it, all the better. Being there for your loved one is very important in this process as well, many agencies require that there is a family member or some other type of support system that can provide assistance if need be.

Some patients may have similar needs but having the same exact combination of needs it extremely rare. Certain agencies have more thorough screening processes in addition to being more selective with the home health aided they hire. The result is a higher quality service that benefits the patients they service.

Inquiring about the processes in place is a good way to check the quality of a companys field staff. Another way to know the quality of a home care agencies staff is to ask about their “in-service programs”. Just like many other companies in other industries offer their employees continuing education courses to keep their skills up to date, so do many home care agencies.

By becoming an informed consumer on locating quality and accessible home health care, a patient can avoid an extended hospital stay or repeated visits to the doctors office. Having the provider picked out before an incident occurs will make certain that you do not end up making a last second decision, bypassing these highly important steps. Accessibility is important – – high quality care is essential.

New drug for advanced colorectal cancer shows promise in trial – Far Infrared Sauna Cabin Manufactu

An experimental drug for advanced colorectal cancer that available treatments have failed to halt, has shown promisein a clinical trial, says Bayer HealthCare, the company that makesit. The results of the phase III trial show that compared toplacebo, regorafenib slowed tumor growth and extended survival. In a statement released yesterday, Bayer announced that the PhaseIII CORRECT (Colorectal cancer treated with regorafenib or placeboafter failure of standard therapy) trial “met its primary endpoint,showing statistically significant improvement in overall survival… in patients with metastatic colorectal cancer (mCRC) whosedisease had progressed after approved standard therapies”. The statement goes on to add that the trial also shows thatregorafenib showed statistically significant improvement inprogression-free survival and improvement in disease control ratein the patients who received the drug compared to those whoreceived placebo.

The trial results show that more of the side effects commonly oroccasionally seen with chemotherapy occurred with the drug thanwith placebo, including fatigue , hand-foot skin reaction, diarrhea , anorexia , high blood pressure , oral mucositis (inflammation of the lining of the mouth) andrash/skin peeling. The trial was “unblinded” late in 2011 after an independent datamonitoring committee said the drug was showing significantimprovement in overall survival and patients receiving placeboshould be offered the option to take it. It was conducted in North America, Europe, China, Japan andAustralia and enrolled 760 patients. Bayer said they will be seeking Food and Drug Administration (FDA)approval for regorafenib within the next 12 months. s.

If approved, itwill be the first new treatment for colorectal cancer in over fiveyears. Dr Axel Grothey, MD, Professor of Oncology at the Mayo Clinic is aco-principal investigator on the trial. He is presenting the trial results at the 2012 Gastrointestinal Cancers Symposium of the American Society ofClinical Oncology (ASCO-GI) , in San Francisco later this week. The oral abstract presentation (LBA number 385) is set to takeplace at 14:30 h PT on 21 January in the Level 3 Ballroom, MosconeCenter West.

Colorectal cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death in the US, in both menand women. About half of patients diagnosed